Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,075.69
+17.030.83%
Number of Gainers:618
Number of Losers:389
Number of Flat:17
PE:- -
High:2,083.23
Open:2,058.90
Low:2,058.90
Close:2,058.66
Volume:6.00B
Turnover:741.53B
Market Cap:96.63T
Float Cap:90.45T

Loading ...

Analysts Conflicted on These Technology Names: Adobe (ADBE) and ON Semiconductor (ON)

TIPRANKS
·
Oct 02

Market Chatter: Microsoft, Amazon Cloud Units Face EU Digital Markets Act Scrutiny

MT Newswires Live
·
Oct 02

Century Therapeutics Targets CNTY-813 IND Filing in Q4 2026, Sees Initial Trial Data in 2H 2027

Reuters
·
Oct 02

Autonomix Medical Wins Canadian Patent for Catheter-Based Transvascular Nerve Therapy Platform

Reuters
·
Oct 02

Integra LifeSciences Q3 Adjusted EPS Seen at $0.55-$0.59; Revenue Seen at $410-$412 Million

Reuters
·
Oct 02

Parry Labs Secures Enterprise Agreement with General Dynamics Land Systems~

THOMSON REUTERS
·
Oct 02

Parry Labs : Signs Five-Year Enterprise License Agreement for Stratia and Viw Software

THOMSON REUTERS
·
Oct 02

NN Inc Prices Unregistered PIPE at $3.30 Per Share for USD 50 Million Net Proceeds

Reuters
·
Oct 02

Duke Robotics Names Avi Levin CFO, Replacing Shlomo Zakai

Reuters
·
Oct 02

Cognizant Schedules Third-Quarter Earnings Release, Conference Call

Reuters
·
Oct 02

Freeport Says Indonesia Smelter Restarts After 2025 Grasberg Incident

Reuters
·
Oct 02

NetSol Technologies Names Michael Ramsey VP of Sales for Transcend Finance Americas

Reuters
·
Oct 02

Constellation Software’s Volaris Acquires Brazil Corporate Foodservice Software Provider Teknisa

Reuters
·
Oct 02

Celcuity Appoints Ex-Incyte CFO David Gryska to Board

Reuters
·
Oct 02

Press Release: Revvity to Hold Earnings Call on November 3, 2026

Dow Jones
·
Oct 02

Surrozen Says FDA Clears IND for SZN-8141 Diabetic Macular Edema Trial

Reuters
·
Oct 02

Thunder Bridge Capital Partners V Units Begin Separate Trading of Shares, Warrants Oct. 5

Reuters
·
Oct 02

Cencora to Report Fourth-Quarter Fiscal 2026 Results, Host Conference Call

Reuters
·
Oct 02

Taysha Gene Therapies Grants New Hires 384,000 RSUs, Options for 92,400 Shares Under Inducement Plan

Reuters
·
Oct 02

Teva Says Phase 3 Ecopipam Trial Halves Tic Relapse Risk in Pediatric Tourette Syndrome Patients

Reuters
·
Oct 02